Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E genotype and schizophrenia.

J Y Chen1, C J Hong, H J Chiu

  • 1Section of Psychiatry, Yu-Li Veterans Hospital, Taipei, Taiwan, ROC.

Neuropsychobiology
|March 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Translational psychiatry·2016
Same author

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Translational psychiatry·2015
Same author

Quantitative determination of atorvastatin and ortho-hydroxy atorvastatin in human plasma by liquid chromatography tandem mass spectrometry and pharmacokinetic evaluation.

Methods and findings in experimental and clinical pharmacology·2010
Same author

Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease.

Dementia and geriatric cognitive disorders·2005
Same author

Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.

Dementia and geriatric cognitive disorders·2004
Same author

ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD.

Neurology·2004
Same journal

Kynurenic Acid Offers Added Value in Predicting ECT Outcomes in Depression.

Neuropsychobiology·2026
Same journal

Decreased Specific Pavlovian-to-Instrumental Transfer Effect in Internet Gaming Disorder Following Short-Term Abstinence from Gaming.

Neuropsychobiology·2026
Same journal

Clinicians' Preferences and Attitudes Toward the Use of Lithium in the Treatment of Bipolar Disorders in Mexico.

Neuropsychobiology·2026
Same journal

Prevalence of psychotic symptoms and their clinical correlates in elderly major depressive disorder patients with subclinical hypothyroidism.

Neuropsychobiology·2026
Same journal

The Long- Term Course of Adolescent-Onset Major Depressive Disorder in Females: A 10-Year Cohort Study on Recurrence, Suicide Risk, and Service Use.

Neuropsychobiology·2026
Same journal

Evidence on Deliberate Self-Harm, Suicidal Ideation and Suicides in Pakistan: A Scoping Review of Methods, Contributing Factors and Associated Mental Disorders.

Neuropsychobiology·2026
See all related articles

Apolipoprotein E (apoE) genotype distribution differs in schizophrenia patients compared to controls. ApoE sigma3 carriers show an increased risk, suggesting apoE

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • Schizophrenia is a complex genetic disorder.
  • Apolipoprotein E (apoE) is linked to neuropsychiatric conditions.
  • Prior research on apoE and schizophrenia shows conflicting results.

Purpose of the Study:

  • To investigate apoE genotype frequencies in a large schizophrenia patient cohort.
  • To clarify the association between apoE isoforms and schizophrenia risk.

Main Methods:

  • Genotype analysis of apolipoprotein E (apoE) in schizophrenic patients and control groups.
  • Statistical comparison of genotype distributions between the two groups.

Main Results:

  • Significant differences in apoE genotype distribution were observed between schizophrenic patients and controls.

Related Experiment Videos

  • Individuals carrying the apoE sigma3 allele demonstrated a higher risk for developing schizophrenia.

    • Conclusions:

    • Apolipoprotein E (apoE) isoforms may influence the pathogenesis of schizophrenia.
    • The findings suggest a functional role for apoE in the development of schizophrenic disorders.